Biomarin Pharmaceutical Inc BMRN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:37 PM EDT
76.97UNCH (UNCH)
Volume
83,323
Close
76.97quote price arrow down-3.43 (-4.27%)
Volume
3,774,707
52 week range
76.02 - 99.56
Loading...
  • Open80.18
  • Day High80.66
  • Day Low76.52
  • Prev Close80.40
  • 52 Week High99.56
  • 52 Week High Date12/14/23
  • 52 Week Low76.02
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap14.615B
  • Shares Out189.88M
  • 10 Day Average Volume1.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-16.61

KEY STATS

  • Open80.18
  • Day High80.66
  • Day Low76.52
  • Prev Close80.40
  • 52 Week High99.56
  • 52 Week High Date12/14/23
  • 52 Week Low76.02
  • 52 Week Low Date11/02/23
  • Market Cap14.615B
  • Shares Out189.88M
  • 10 Day Average Volume1.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-16.61

RATIOS/PROFITABILITY

  • EPS (TTM)1.06
  • P/E (TTM)72.85
  • Fwd P/E (NTM)43.76
  • EBITDA (TTM)282.527M
  • ROE (TTM)4.22%
  • Revenue (TTM)2.472B
  • Gross Margin (TTM)79.22%
  • Net Margin (TTM)8.31%
  • Debt To Equity (MRQ)21.44%

EVENTS

  • Earnings Date07/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomarin Pharmaceutical Inc

Profile

MORE
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme...
Richard Meier
Non-Executive Independent Chairman of the Board
Alexander Hardy
President, Chief Executive Officer, Director
Brian Mueller CPA
Chief Financial Officer, Executive Vice President - Finance
Erin Burkhart
Group Vice President, Chief Accounting Officer
C. Greg Guyer Ph.D.
Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
Address
105 Digital Dr
Novato, CA
94949-8703
United States

Top Peers

SYMBOLLASTCHG%CHG
RPRX
Royalty Pharma PLC
27.88-0.12-0.43%
UTHR
United Therapeutics Corp
272.22-0.47-0.17%
CTLT
Catalent Inc
55.25-0.36-0.65%
ELAN
Elanco Animal Health Inc
16.98-0.06-0.35%
AMRX
Amneal Pharmaceuticals Inc
6.75-0.12-1.75%